13:39 EDT Tenax Therapeutics (TENX) trading halted, volatility trading pause
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TENX:
- Tenax Therapeutics Approves Officer Exculpation Amendment
- Tenax Therapeutics Reports Increased Losses Amid Strategic Investments
- Positive Buy Rating for Tenax Therapeutics Driven by Promising Clinical Trials and Strong Financial Position
- Tenax Therapeutics price target lowered to $15 from $16 at Guggenheim
- Tenax Therapeutics reports Q1 EPS (28c), consensus (41c)